The Pfizer logo is seen in this illustration taken August 3, 2025. Dado Ruvic/Illustration
The Pfizer logo is seen in this illustration taken August 3, 2025. Dado Ruvic/Illustration

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

July 30th, 2026 | 11:48 AM BUSINESS Healthcare & Pharmaceuticals 1

Facebook Twitter Google+ LinkedIn Pinterest
By Reuters

Pfizer (PFE.N) said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in ​two late-stage trials, paving the way for regulatory submissions seeking ‌approval in the autoimmune skin disease.

Here are the details:

Related Posts

© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT